Dermata Therapeutics Names Kyri Van Hoose New CFO

(RTTNews) - Dermata Therapeutics, Inc. (DRMA) on Wednesday announced the appointment of Kyri Van Hoose as Senior Vice President and Chief Financial Officer.

Van Hoose replaces Thomas Insley, who is retiring after six years of service as CFO and plans to continue with the company as a financial consultant.

Van Hoose has more than 20 years experience as financial leader with above 15 years in the life sciences industry.

"Kyri's extensive financial experience in the life sciences industry and experience with public companies will support our programs for the continued development of DMT310 and DMT410," said Gerry Proehl, Dermata's Chief Executive Officer.